Tao2025-02-21T13:17:02+00:0028-01-2025|News, Press Release|
The World Economic Forum (WEF)'s annual meeting in Davos, Switzerland has long been a leading gathering where global leaders in business, policymaking and activism converge to address critical international challenges. This year's meeting, held from January 20 to 24, 2025, focused on the theme "Collaboration for the Intelligent Age", with priorities including rebuilding trust, [...]
Tao2025-01-10T10:21:21+00:0003-12-2024|News, Press Release|
We are at a historical crossroads in the management of Alzheimer’s disease, with new treatments becoming available in various countries. For the first time in history, science is delivering new, potentially disease-modifying treatments for devastating diseases such as Alzheimer’s disease. However, the current healthcare system and regulatory frameworks do not [...]
admin_ebc2024-10-08T08:41:00+00:0026-09-2024|News, Press Release|
The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), is very pleased to launch the "Rethinking Alzheimer's Disease Pathway: From Diagnosis to Care" Perspective Paper on the occasion of the World Alzheimer's Month. The aim of this report is not merely to document the status quo, [...]
Dominika Suchonova2024-05-03T08:34:26+00:0002-05-2024|News|
The 36th Global Conference of Alzheimer’s Disease International (ADI) took place in Kraków, Poland from 24-26 April 2024, with ADI member Polskie Stowarzyszenie Pomocy Osobom z Chorobą Alzheimera (Polish Alzheimer’s Association). Held under the overarching theme of "Dementia: Insights. Innovations. Inspirations.", the conference brought together more than 1000 delegates from over 100 countries to share [...]
Dominika Suchonova2024-03-18T14:40:58+00:0007-02-2024|
EBC is pleased to be part of the session “Diagnosis, diagnostic tools and cognitive assessments” at the upcoming 36th Global Conference of Alzheimer’s Disease International. The session will take place on 26 April 2024 at 13:30-15:00 in Krakow (Poland). Prof. Giovanni Frisoni will present "Rethinking Alzheimer's disease: Scaling up health systems' readiness" as one [...]
Dominika Suchonova2024-03-18T14:31:24+00:0007-02-2024|
EBC is pleased to hold a poster presentation "Rethinking Alzheimer’s disease: Cross-roads in the earlier detection and diagnosis of Alzheimer's" at the upcoming 36th Global Conference of Alzheimer's Disease International. The Conference will take place from 24-26 April 2024 in Krakow (Poland). The poster will be presented by Charlotte Teunissen, Professor in Neurochemistry, Chair [...]
Dominika Suchonova2024-03-13T13:37:41+00:0003-01-2024|
The 36th Global Conference of Alzheimer’s Disease International will take place in Kraków, Poland from 24-26 April 2024, with ADI member Polskie Stowarzyszenie Pomocy Osobom z Chorobą Alzheimera (Polish Alzheimer’s Association). Coming together under the conference theme of ‘Dementia: Insights. Innovations. Inspirations.’, the conference will bring together experts from across the world to share [...]
Dominika Suchonova2023-11-28T14:12:48+00:0028-11-2023|
The Alzheimer's and Parkinson's Diseases Conference (AD/PD™) will take place on 5-9 March 2024 in Lisbon (Portugal) and virtually. The AD/PD™ Conference is where the brightest minds gather to explore the latest research, clinical trials, and treatments for Alzheimer's and Parkinson's. From uncovering groundbreaking discoveries to sharing the latest developments in treatments. The Conference [...]
Dominika Suchonova2023-10-18T08:22:54+00:0013-10-2023|News|
EBC was honoured to be part of the Defeating Dementia Conference, bringing together leading experts in dementia, which took place on 2 October 2023 in The Hague. The event was organised by the Ministry of Health, Welfare and Sport of The Netherlands in collaboration with the World Dementia Council. Representatives from G20 governments, international institutions, [...]
Dominika Suchonova2023-10-09T09:28:30+00:0009-10-2023|News|
Alzheimer's disease, the most common form of dementia, is a pressing issue for our lifetime. Society needs to be responsive to ensure that people can live with more dignity and access services and resources despite their diagnosis. On 26 September 2023, the European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical [...]